Non-invasive examination for the determination of the fetal trisomies 21, 18 und 13 such as Klinefelter syndrome, Turner-, Triple X-, XYY syndrome and a 22q11.2 microdeletion (associated with DiGeorge syndrome)
Starting from the ninth week of pregnancy (9+0 weeks since LMP) the PrenaTest® determines trisomies 21, 18 and 13, gonosomal aneuploidies (Turner, triple X, Klinefelter, and XYY syndromes) as well as the 22q11.2 microdeletion – associated with the DiGeorge syndrome- (in combination with PrenaTest® option 2 or 3) from maternal blood. If desired, the gender of the fetus may also be determined. The PrenaTest® can also be performed in the case of a twin pregnancy, following fertility treatment – as well as egg donation.
With the PrenaTest®, you can fully implement the recommendations of medical associations in Germany, Austria and Switzerland, as it offers the appropriate test panel.